Search

everythinglearnresearchcommunity

for

Search:↓

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Males with acne are more likely to have Metabolic Syndrome.

PCOS may be linked to spina bifida in young females.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Certain blood metabolites are linked to female pattern hair loss, with some increasing risk and others offering protection.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Type 2 diabetes in youth is increasing, with high treatment failure rates and more severe than Type 1; certain drugs can lower lipid levels effectively with varying side effects, and apples may benefit heart health like statins but with fewer side effects.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

Early life factors, including a mother's health and environment, can affect the chances of developing polycystic ovary syndrome later in life.

Children with metabolic syndrome often have skin problems like dark patches, skin tags, stretch marks, infections, acne, and psoriasis, which are linked to obesity and insulin resistance.

Hair follicle stem cells prevent melanocyte stem cells from differentiating by controlling retinoic acid levels.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Nearly half of women with PCOS have metabolic syndrome, and lifestyle changes are crucial to prevent complications.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.

Patients with mycosis fungoides have a higher risk of heart disease.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Women with PCOS have a higher risk of heart disease.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Early hair loss may indicate higher risk of diabetes and heart disease.

High chromogranin A levels are linked to obesity and inflammation in polycystic ovary syndrome.

Skin changes can signal diabetes and metabolic issues, aiding early diagnosis and treatment.

The study found that family history, personal history of adolescent acne, no pregnancies, hirsutism, office work, stress, and low intake of fruits/vegetables and fish are risk factors for adult female acne.

Changes in SHBG levels don't predict diabetes risk reduction.